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Methacholine challenge studies are often conducted to diagnose asthma in patients with mild or intermittent respiratory symptoms when screening spirometry results are normal. We hypothesized that in patients with increased nonspecific bronchial hyperreactivity (NSB-HR), gas trapping might be present and that this information could be a factor in clinical decision making. To assess the relationship between gas trapping and NSBHR, we conducted a retrospective chart review of 500 patients who had undergone pulmonary function testing, including lung volume measurement and methacholine challenge. Measurements of airflow, lung volumes, and methacholine PC20 values were compiled and analyzed. FRC was determined by body plethysmography (FRCB) and by helium dilution (FRC-He). FRCB-FRC-He, RV (percent of predicted) RV/TLC, and RV/TLC (percent of predicted) were used as measures of gas trapping. RV% and RV/TLC% were the best predictors of a PC20 ' 8 mg/mL. In equations.2 The following were considered to be indicative of gas trapping: FRCB-FRC-He >-500 mL; residual volume (RV) >130% predicted; and RV/total lung capacity (TLC) >120% predicted.
Methacholine inhalation challenge tests were performed according to the method described previously by Hargreave and coworkers. 3 The level of bronchial hyperreactivity was expressed as the PC20. Testing was conducted using increasing concentrations of methacholine up to 16 mg/mL or until FEVy decreased by 20% or more from the baseline value. A PC20 ' 8 was considered to represent a positive test.
Statistical Analysis
Results are expressed as either proportions or means ± SDs. Correlations between PC20 values and measures of gas trapping were assessed by least squares linear regression. Contingency tables (2X2) were constructed for methacholine challenge tests and gas trapping. Sensitivity, specificity, positive and negative predictive values, and X2 were calculated from these tables. Results were considered significant at p<0.05.
RESULTS

Demographics
Of the 500 patients reviewed, 310 were women and 190 were men. The mean age of the study population was 37.7 ± 14 years (range, 8 to 76 years). In 451 of the patients, the pretest diagnosis as indicated on the pulmonary function test requisition was asthma, possible asthma, or no specific diagnosis recorded. The remaining 49 cases had other respiratory diagnoses indicated: these included bronchitis (21), sleep apnea (11), COPD (5), bronchiectasis (2), pneumonia (2) , and various other disorders (1 each), including multiple sclerosis, bronchiolitis, upper respiratory tract infection, sarcoidosis, hypersensitivity pneumonitis, latex allergy, pulmonary nodule, and chemical exposure.
Correlation of PC20 With Gas Trapping
In 185 of the cases selected, the patient had a PC20 value .16 mg/mL. In these patients, PC20 did not correlate significantly with any of the measures of gas trapping (Table 1) . A positive challenge (PC20 < 8 mg/mL) was present in 152 (30.4%) of the 500 patients and in 72 of the 169 patients with an FEV1/FVC <90%.
Sensitivity and Specificity x2 values were obtained for each of the four measures of gas trapping when used as a predictor of a PC20 .8 mg/mL at various thresholds (Table 2 ). For FRCB-FRC-He, x2 was significant at 0.6 L or higher but not at 0.5 L. The RV (percent of predicted) gave statistically significant results at all levels (130% or higher). RV/TLC, while significant at ratios of 30 and 50, was not significant at 40. However, when RV/TLC (percent of predicted) was examined, it was found to be significant at all levels (120% and up). Of the four parameters used, RV/TLC (percent of predicted) was the most predictive of a positive methacholine challenge, followed by RV (percent of predicted).
The most sensitive test (53.9%) was RV/TLC at a threshold of 30; however, the specificity (56.0%), positive predictive value (34.9%), and negative predictive value (26.4%) of this parameter were all much lower than was seen with other measures. RV/TLC at 50, in contrast, was specific (99.1%) and displayed the best positive predictive value (72.7%), but with low sensitivity (5.3%). This pattern of low sensitivity and high specificity was seen with all other measures; somewhat higher positive predictive values were seen with RV/TLC (percent of predicted) (range, 43. 8 
74.3%).
In 169 of the 500 patients, the patient's FEV1/FVC ratio was >-90% of the predicted value before methacholine challenge. When the above analysis was applied to this subset of patients, different results were seen (Table 3) . Of the same four gas trapping parameters, only RV/TLC (percent of predicted) was predictive of a PC20'8 mg/mL and only at a threshold of 125% or higher; 120% was not significant. None of FRCB-FRC-He, RV (percent of predicted), or RV/TLC were significant at any of the levels tested.
The incidence of hyperresponsiveness in patients with FEV1/ FVC less than 90% was 42.6% (72/169). The sensitivity of an FEV1/FVC ratio of less than 90% in predicting positive methacholine challenge studies (PC20<8 mg/mL) is 52.6%. The specificity is 27.9%. The positive and negative predicted values are 24.2% and 57.4%, respectively.
Within the range 125 to 135%, RV/TLC (percent of predicted) was relatively insensitive (range, 16.7 to 27.8%) but quite specific (range, 87.6 to 95.9%). Although this subset of patients showed moderately higher positive predictive values (range, 62.5 to 75.0%) than were seen above in the whole group of 500 patients, the negative predictive values were somewhat lower in this subset (range, 60.8 to 62.0%).
Sixty-one percent (n=309) of patients described themselves as nonsmokers while 24.4% (n=122) described themselves as smokers. Smoking status was not recorded by 13.8% (n=69). Knowledge of patients' smoking status did not alter the predictive values of gas trapping.
DISCUSSION
Our data indicate that in patients with normal or nondiagnostic results of spirometry, the presence of gas trapping raises the prior probability that nonspecific bronchial hyperreactivity (NSBHR) will be found by methacholine challenge. The diagnostic usefulness of measures of gas trapping in this setting has not been assessed, although gas trapping is a well-known feature of asthma and in some cases may be the only pulmonary function abnormality detectable in asthmatics during asymptomatic periods.4
The presence and severity of asthma are known to correlate with the degree of increase in NSBHR and a test such as a methacholine challenge, which measures NSBHR directly, is a sensitive means of diagnosing asthma.5-7 This study failed to show a correlation between the amount of gas trapping and the degree of NSBHR. Our analysis, however, was predominantly (although not exclusively) limited to patients with normal or nondiagnostic results of spirometry. That is, patients with more severe disease would have been detected spirometrically and methacholine challenge would not have been performed. The lack of correlation between the amount of gas trapping and degree of NSBHR might simply be reflective of the limited spectrum of disease severity reviewed. Similarly, it must be noted that the diagnostic value of lung volume measurements may have been underestimated in our study. We examined the data from patients who had been referred by their physicians for methacholine challenge testing. It is possible that physicians were more likely to request such studies in patients with increased RV.
Our data suggest that measures of gas trapping can be applied to assess whether patients who have undergone pulmonary function testing have a high or low probability of having increased NSBHR. Generally, this approach has high specificity but low sensitivity. Gas trapping predicts a positive methacholine challenge in 45 to 65% of cases, depending on the parameter and the threshold used; absence of gas trapping is associated with a negative challenge more than 70% of the time. In the population studied, it would appear initially that any of the four parameters indicative of gas trapping can be used for this purpose, although RV (percent of predicted) and RV/TLC (percent of predicted) tended to give better results than FRCB-FRC-He. The latter observation may be related to the need for two separate maneuvers and experimental set-ups in order to calculate the last parameter, with an associated increased chance of error. Although RV/TLC assessed as the calculated ratio alone produced the greatest specificity and positive predictive value, the extremely low sensitivity of this measure would severely limit its usefulness as very few The present study has not incorporated the clinical history of the patients tested nor has it excluded the possibility of another disease state that may lead to an increase in RV; it is possible that the predictive values would be even higher if the analysis was restricted to patients with symptoms highly suggestive of asthma.
The use of spirometry in the diagnosis of respiratory disease is well accepted and widely used. Its value, however, is subject to limitations, the most important being that the results are highly dependent on patient effort. Although this variable is controlled by obtaining multiple respiratory efforts and the subjective impressions of the examiner, results may not be reliable in all subjects. Furthermore, there is evidence that failure to satisfy American Thoracic Society criteria itself correlates positively with bronchial hyperresponsiveness9 and thus its use as an exclusion criterion in this study may represent a source of bias. In addition, the methacholine challenge, although quite sensitive for the diagnosis of asthma, is also subject to problems such as false positives from other diseases as well as false negatives depending on the severity of asthma, medication use, and perhaps the season.6'10'11 The degree of bronchial hyperresponsiveness may be variable on different occasions, a fact that cannot be appreciated with a single challenge test result; these factors must be borne in mind if methacholine challenge is to be used as a diagnostic tool for asthma.12
In summary, it appears that patients with gas trapping have an increased likelihood of having a positive methacholine challenge. RV/TLC (percent of predicted) is the best such parameter to apply and is predictive of a positive methacholine challenge even in patients with normal airflows if a threshold value of at least 125% is used as the upper limit of normal. This measure might therefore be applied to raise the clinical suspicion of asthma in the large population of patients presenting with respiratory symptoms and normal flow rates.
